International Journal of
Advanced Multidisciplinary Application

Volume 3, Issue 5

• Author(s)Deepa Nair, Subhash Tripathi, Moumita Ghosh
• AffiliationDepartment of Pharmaceutics, Amrita School of Pharmacy, Kochi, Kerala, India
• Page No.120-124
• Volume, Issue & YearVolume 3, Issue 5, May 2026
• Published On2026/05/16
• JournalInternational Journal of Advanced Multidisciplinary Application (IJAMA)
• ISSN No.3048-9350
• DOIhttps://doi.org/10.5281/zenodo.20424192

Abstract

Curcumin (diferuloylmethane), the principal bioactive polyphenol of Curcuma longa, exhibits documented antiproliferative, anti-inflammatory, and pro-apoptotic activity across multiple cancer cell lines, yet its clinical translation is severely hampered by pharmacokinetic limitations including aqueous solubility below 11 ng/mL at physiological pH, extensive first-pass metabolism, and rapid systemic clearance yielding oral bioavailability typically below 1% in humans. Polymeric nanoparticle encapsulation using mucoadhesive polysaccharides that resist gastric and small intestinal degradation while releasing cargo in the colonic environment — exploiting colonic pH (6.5–7.4) and microbial enzyme-mediated polymer degradation — represents a promising strategy for colon-targeted curcumin delivery. This study reports the preparation, optimisation, and in vitro characterisation of chitosan-sodium alginate nanoparticles (CS-SA NPs) loaded with curcumin via ionic gelation method, investigating the effect of four chitosan:alginate polymer ratios (1:1, 1:2, 2:1, and 1:3 w/w) on encapsulation efficiency (EE%), drug loading capacity (DLC), particle size, zeta potential, polydispersity index (PDI), and in vitro release profile. Optimal formulation (CS:SA = 1:2, designated F3) achieves EE of 84.3 ± 2.1%, particle size 186 ± 12 nm, PDI 0.183, zeta potential -28.4 ± 1.8 mV, and cumulative curcumin release of 78.6% at 24 hours under simulated colonic fluid (pH 6.8, rat caecal content 2% w/v). In vitro cytotoxicity against HCT-116 colon cancer cell line confirms IC50 of 8.4 µg/mL for F3 nanoparticles versus 42.6 µg/mL for free curcumin solution — a 5.1-fold enhancement attributed to nanoparticle-mediated cellular uptake enhancement and sustained intracellular release. FTIR and DSC analysis confirm curcumin encapsulation and polymer-drug compatibility. These results support further in vivo evaluation of CS-SA nanoparticles as a colon-targeted curcumin delivery platform.

Keywords: curcumin, chitosan, alginate, nanoparticles, colon cancer, drug delivery, ionic gelation, HCT-116, encapsulation efficiency, release kinetics, zeta potential

References

1. [1] Aggarwal, B. B., & Harikumar, K. B. (2009). Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. International Journal of Biochemistry and Cell Biology, 41(1), 40-59.
2. [2] Azevedo, M. A., Bourbon, A. I., Vicente, A. A., & Cerqueira, M. A. (2014). Alginate/chitosan nanoparticles for encapsulation and controlled release of vitamin B2. International Journal of Biological Macromolecules, 71, 141-146.
3. [3] Bhatia, S. (2016). Natural Polymer Drug Delivery Systems: Nanoparticles, Plants, and Algae. Springer International Publishing.
4. [4] Jain, A., Jain, S. K., Ganesh, N., Barve, J., & Beg, A. M. (2010). Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer. Nanomedicine, 6(1), 179-190.
5. [5] Maheshwari, R. K., Singh, A. K., Gaddipati, J., & Srimal, R. C. (2006). Multiple biological activities of curcumin: A short review. Life Sciences, 78(18), 2081-2087.
6. [6] Mukhopadhyay, P., Chakraborty, S., Bhattacharya, S., Mishra, R., & Kundu, P. P. (2015). pH-sensitive chitosan/alginate core-shell nanoparticles for efficient and safe oral insulin delivery. International Journal of Biological Macromolecules, 72, 640-648.
7. [7] Sarmento, B., Ribeiro, A., Veiga, F., Sampaio, P., Neufeld, R., & Ferreira, D. (2007). Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharmaceutical Research, 24(12), 2198-2206.
8. [8] Shen, L., Ji, H. F., & Zhang, H. Y. (2007). A TD-DFT study on the photophysical properties of curcumin. Chemical Physics Letters, 439(1-3), 211-214.
9. [9] Yallapu, M. M., Jaggi, M., & Chauhan, S. C. (2012). Curcumin nanoformulations: A future nanomedicine for cancer. Drug Discovery Today, 17(1-2), 71-80.
10. [10] Zhang, W., Hu, X., Shen, Q., & Xing, D. (2019). Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enha

Explore Our Related Journals

Looking for the right journal for your next manuscript? Explore our international peer-reviewed journals covering engineering, management, computer science, artificial intelligence and multidisciplinary research.